Quantification of airborne SARS-CoV-2 genomic particles in different hospital settings

Sci Rep. 2021 Oct 28;11(1):21284. doi: 10.1038/s41598-021-00761-1.

Abstract

We quantified the presence of SARS-CoV-2 RNA in the air of different hospital settings and the autopsy room of the largest medical centre in Sao Paulo, Brazil. Real-time reverse-transcription PCR was used to determine the presence of the envelope protein of SARS-CoV-2 and the nucleocapsid protein genes. The E-gene was detected in 5 out of 6 samples at the ICU-COVID-19 ward and in 5 out of 7 samples at the ward-COVID-19. Similarly, in the non-dedicated facilities, the E-gene was detected in 5 out of 6 samples collected in the ICU and 4 out of 7 samples in the ward. In the necropsy room, 6 out of 7 samples were positive for the E-gene. When both wards were compared, the non-COVID ward presented a significantly higher concentration of the E-gene than in the COVID-19 ward (p = 0.003). There was no significant difference in E-gene concentration between the ICU-COVID-19 and the ICU (p = 0.548). Likewise, there was no significant difference among E-gene concentrations found in the autopsy room versus the ICUs and wards (dedicated or not) (p = 0.245). Our results show the widespread presence of aerosol contamination in different hospital units.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerosols
  • Air Microbiology*
  • Autopsy
  • Brazil / epidemiology
  • COVID-19 / epidemiology
  • COVID-19 / transmission
  • COVID-19 / virology*
  • COVID-19 Nucleic Acid Testing
  • Genome, Viral
  • Hospital Units
  • Hospitals*
  • Humans
  • Intensive Care Units
  • Pandemics
  • Pathology Department, Hospital
  • RNA, Viral / analysis
  • RNA, Viral / genetics
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / isolation & purification*
  • Virion / genetics
  • Virion / isolation & purification

Substances

  • Aerosols
  • RNA, Viral